Move could herald an attempt to salvage deal with McKesson, the US pharma distributor, whose planned acquisition failed to secure shareholder support Source
This site uses Cookies to dispense or record information with regards to your visit. By continuing to use this site you agree to the terms outlined in ourCookies used here:Privacy / Disclaimer,